Pyxis Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PYXS Nasdaq 8731 https://pyxisoncology.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Pyxis Oncology Inc

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - Aug 29th, 2024 11:30 am
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - Aug 14th, 2024 8:05 pm
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Jul 29th, 2024 12:00 pm
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 28th, 2024 8:30 pm
Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green - Jun 20th, 2024 12:43 pm
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger - Jun 10th, 2024 11:30 am
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference - May 30th, 2024 11:30 am
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 - May 14th, 2024 11:30 am
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference - May 9th, 2024 11:30 am
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights - Mar 27th, 2024 11:30 am
Pyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challenges - Mar 21st, 2024 1:11 pm
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 - Mar 21st, 2024 11:30 am
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA - Mar 13th, 2024 12:00 pm
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 - Mar 7th, 2024 9:30 pm
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting - Mar 5th, 2024 9:45 pm
Pyxis Oncology Announces $50 Million Private Placement - Feb 27th, 2024 1:00 pm
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer - Nov 28th, 2023 12:00 pm
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update - Nov 7th, 2023 9:30 pm